Tag

hip replacement Archives - Carey Danis & Lowe

UK Prohibits Metal-on-Metal Hip Implants

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

depuy_hip_replacement_asr_kransky_settlement_verdict_lawsuitFollowing a study whose data revealed an unusually high failure rate of 43 percent for certain types of metal-on-metal hip implants, the UK has prohibited the use of these types of hip implants in National Health Service (NHS) hospitals. Involving 17,000 participants, the study recorded a significant number of instances wherein metal-on-metal hip implants showed signs of serious erosion.

The Telegraph found that many metal-on-metal hip implants do not meet failure rate standards, especially the DePuy ASR Hip Replacement system. This hip implant has a documented failure rate of 13 percent over a five year period. That failure rate increases with time, as some estimates show a 43 percent rate of failure nine years after initial implantation.

Due to its defective natu, the DePuy ASR hip implant has since been removed from the market.

According to a former president of the British Orthopaedic Association, who was interviewed for the Telegraph report, if left in the body, a defective metal-on-metal hip replacement can damage surrounding tissue.

The U.S. Food and Drug Administration (FDA) has also warned about the harm metal-on-metal hip implants can cause. The FDA has noted that metal-on-metal hip implants have been known to release metal particles into the body, and as such, destroy surrounding tissue and bone. Metal particles can also enter the bloodstream, and cause neurological problems.

How can Carey Danis & Lowe Help You?

If you received an implant of the DePuy ASR Hip Replacement system, and have experienced health complications that you believe are the result of device failure and defective design, you have a case that may make you eligible to receive compensation. The defective medical device attorneys at Carey Danis & Lowe are currently investigating cases involving the DePuy ASR Hip Replacement. We invite you to contact our St. Louis based law firm for a free case evaluation, and for assistance with filing a DePuy ASR Hip lawsuit.

If you have concerns about how metal-on-metal hip implants can impact health, speak with one of our on-staff medical experts.

Share your DePuy ASR Hip story with Carey Danis & Lowe today. Call us at 800.721.2519, or complete a confidential personal injury claim.

DePuy ASR Hip Lawsuit News: DePuy ASR Settlement in San Francisco Superior Court

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

depuy_hip_replacement_asr_kransky_settlement_verdict_lawsuitA settlement is under negotiation in a DePuy ASR hip lawsuit in San Francisco Superior Court. The case, involving plaintiff Robert Eugene Ottman, was intended to be the first case to go to trial among a pool of DePuy ASR hip lawsuits in the California state court. However, rather than beginning trial proceedings, DePuy Orthopaedics made efforts to begin the settlement process.

Settlement details between Ottman and DePuy, a Johnson & Johnson unit, have not yet been made public.

DePuy ASR lawyers at Carey Danis & Lowe are optimistic about the future of DePuy ASR hip lawsuits following this settlement negotiation in California. The movement to settle rather than enter into a trial demonstrates that DePuy may be more inclined to settle future cases.

In fact, Bloomberg reported in August 2013 that DePuy was deliberating a $3 billion settlement of over 11,000.

Defective Metal-on-Metal Design

The DePuy ASR hip models feature a metal-on-metal design that has been linked to metal poisoning. Plaintiffs who have filed DePuy ASR hip lawsuits claim that DePuy’s metal-on-metal hip replacement features a defective design, wherein metal components of the hip replacement come into contact, causing the release of metal flakes into the bloodstream and surrounding bone and tissue. In addition to damaging bone and tissue, these metal particles have been known to cause neurological problems, according to the U.S. Food and Drug Administration (FDA).

Furthermore, the DePuy ASR hip models have abnormally high failure rates of between 12 – 13 % between the ASR XL Acetabular System and the ASR Hip Resurfacing System. As a result of such a high rate of failure, patients who received a DePuy ASR hip replacement have undergone numerous revision surgeries to repair damage from the ASR hip and to insert a new hip replacement.

Share Your DePuy ASR Hip Story

DePuy ASR hip attorneys at Carey Danis & Lowe are currently accepting DePuy ASR hip cases. Contact Carey Danis & Lowe today for a free legal evaluation of your DePuy ASR hip case, and for more information about your compensation eligibility. You can also speak with one of our on-staff medical experts about health complications related to the DePuy ASR hip replacement.

Share your DePuy ASR hip story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a personal injury claim form.

DePuy ASR Hip Replacement Trial Scheduled to Begin on January 22, 2013 in California Superior Court

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

DePuy ASR Hip Replacement Trial Scheduled to Begin on January 22, 2013 in California Superior CourtInformation from a Johnson & Johnson internal study into the safety of the DePuy ASR Hip Replacement system is suggestive that the medical device manufacturer understood the serious risks associated with their hip implant.

The Johnson & Johnson internal study was recently unsealed in pretrial proceedings in a DePuy ASR Hip Replacement lawsuit in California, overseen by Judge J. Stephen Czuleger. As detailed in the internal study document, the DePuy hip implant proved defective, having a significantly high failure rate with approximately 40% of patients experiencing health complications and requiring revision surgeries after only five years.

Johnson & Johnson has never made public the data gathered in its internal study into its metal-on-metal hip replacement system, according to the New York Times. The reasons for withholding research findings is unclear. Though it may be assumed that one motivation for safeguarding the internal study could be the fact that, in the Johnson & Johnson report, there is the indication that revision surgery will be required for thousands more individuals who received the metal-on-metal DePuy hip implant.

In providing a statement for the New York Times article, a DePuy spokeswoman named Mindy Tinsley, stated that the Johnson & Johnson internal study illustrates data amassed from very limited sources, and therefore, can be used to neither generalize the high failure rate of the DePuy ASR Hip Replacement system nor the most commonly reported health complications linked to Johnson & Johson’s hip implant device.

Now with the Johnson & Johnson internal study document made public, the first in over 10,000 DePuy ASR Hip Replacement lawsuits was scheduled to begin trial proceedings on January 22, 2013 in a California Superior Court in Los Angeles County. According to court documents, the plaintiff, a North Dakota resident named Loren Kransky, filed his DePuy ASR Hip Replacement lawsuit claiming that he developed metallosis, or metal poisoning, as a result of DePuy’s metal-on-metal design that causes metal particles to release from the device and enter the bloodstream.

The U.S. Food and Drug Administration (FDA) has observed cases of neurological damage resulting from exposure to metal ions in the bloodstream. Furthermore, there is also the potential for the tissues and bone surrounding the hip replacement to deteriorate and weaken due to the presence of metal ions.

If you or someone you love has experienced serious health complications resulting from a defective DePuy ASR Hip implant, you may be entitled to receive compensation for your medical expenses, lost wages, and undue suffering.

For a free legal evaluation regarding your defective hip replacement case, contact a lawyer at Carey Danis & Lowe today by calling 800.721.2519.

FDA Releases Safety Communication about Metal-On-Metal Hip Implants: New Safety Communication Warns About High Failure Rates and Metal Ion Reactions

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

FDA Releases Safety Communication about Metal-On-Metal Hip Implants: New Safety Communication Warns About High Failure Rates and Metal Ion ReactionsThe U.S. Food & Drug Administration (FDA) issued an updated safety communication regarding metal-on-metal hip implants on January 17, 2013. The safety communication reports how metal-on-metal hip replacement systems by design have early and high failure rates.

Furthermore, as a result of the hip replacement components making contact with one another during movement like walking or running, metal particles are released into the patient’s body and bloodstream, which may result in what the FDA calls adverse local tissue reactions (ALTR).

As detailed in the FDA’s safety alert, some patients are more likely than others to experience an accelerated degree of hip implant degradation and adverse local tissue reactions. High failure rates in metal-on-metal hip implants and adverse reactions could be the result of an active lifestyle, patients with kidney problems, poor immune system, and a number of other factors.

Though the FDA is not clear on the exact level of metal ions in the bloodstream that cause health complications, they have established frequent adverse reactions to metal ions of cobalt, chromium, and molybdenum. These reactions include:

  • skin rashes
  • cardiomyopathy
  • problems seeing and/or hearing
  • depression
  • kidney malfunction
  • thyroid complications

It is important to meet with an orthopedic surgeon immediately if you begin to experience any of these adverse reactions after receiving a metal-on-metal hip implant. In addition to the health complications outlined above, further adverse reactions include:

  • pain
  • inflammation
  • numbness
  • noise emanating from the hip implant
  • difficulty moving and walking

The FDA released this new safety communication after analyzing information gathered at the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee, which was held in June 2012. This Advisory Committee was assembled by the FDA in order to draw information from experts on metal-on-metal hip replacement systems.

With the new safety announcement, the FDA has since brought forth a new measure that orders manufacturers of metal-on-metal hip replacements, such as Johnson & Johnson’s DePuy, to turn in premarket approval (PMA) applications to the FDA.

Lawyers at Carey Danis & Lowe are currently evaluating DePuy ASR Hip Replacement lawsuits and other metal-on-metal hip replacement claims. If you or someone you love has experienced health complications arising from a defective hip implant, you and your love one may be entitled to receive compensation for your medical expenses, lost wages, and pain and suffering.

For a free legal consultation regarding your DePuy ASR Hip Replacement lawsuit or defective hip replacement lawsuit, contact an experienced trial lawyer at Carey Danis & Lowe by calling 800.721.2519.

DePuy ASR Hip Replacement Lawsuit Update: Trials Scheduled to Begin this Year in Maryland, New Jersey, and Ohio

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

DePuy ASR Hip Replacement Lawsuit Update: Trials Scheduled to Begin this Year in Maryland, New Jersey, and OhioAround the country, individuals have been filing DePuy ASR Hip Replacement lawsuits, and a handful of these suits are slated to begin trial later this year. DePuy ASR Hip Replacement cases are pending in Ohio, Maryland, California, and New Jersey.

One trial being heard in Maryland was scheduled to begin on January 7, 2013, but court proceedings have since been stopped as the plaintiff considers consolidating the case into a federal court in Ohio. The case is Jackson v. DePuy Orthopaedics Inc., which up until the trial cessation was being heard in a Circuit Court in Prince George’s County in Upper Marlboro, Maryland, presided over by Judge Crystal Dixon Mittelstaedt.

Though the Jackson trial is stalled for an uncertain period of time, Johnson & Johnson is attempting to hinder an orthopedic surgeon, Dr. Robert Snowden, from presenting testimony as the plaintiff’s expert witness. According to a Bloomberg article about the Jackson case, Dr. Snowden intended to share with the jury the cancer risks tied to the DePuy ASR Hip Replacement system.

In venturing to block Dr. Snowden’s testimony, Johnson & Johnson argued that Dr. Snowden has no qualifications that would render him an authority on the cancer risks connected to the DePuy metal on metal hip.

In a New Jersey Superior Court, the first DePuy ASR Hip Replacement lawsuit will go on trial on September 9, 2013, with the second trial following soon after on October 21, 2013.

DePuy ASR Hip lawsuits are also being heard in Ohio, and have been consolidated into a Multi-District Litigation (MDL) in the U.S. District Court for the Northern District of Ohio in Toledo. The MDL is in re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation MDL no. 2197. The first trial in the Ohio federal court is scheduled to begin on May 6, 2013, with the second trial scheduled for July 8, 2013.

Plaintiffs who have filed DePuy ASR Hip Replacement lawsuits around the country have claimed that the device has resulted in seriously compromised health as well as numerous revision surgeries. Many plaintiffs allege that the metal-on-metal design of the ASR Hip Replacement system results in metallosis, or metal poisoning.

According to the U.S. Food and Drug Administration (FDA), metal-on-metal hip replacement systems, such as DePuy’s ASR Hip Replacement device, have a metal ball and a metal cup that brush against one another, and in doing so, scrape off metal particles of cobalt and chromium. These metal ions then enter into the bloodstream as well as damage the tissues and bones around the metal-on-metal hip replacement.

The FDA refers to the deterioration of tissue and bone following exposure to metal ions as adverse local tissue reaction (ALTR) or adverse reaction to metal debris (ARMD).

In addition to severe tissue and bone damage, the FDA has also identified a slew of neurological problems related to the DePuy ASR Hip Replacement system, as well as other metal-on-metal hip replacement devices. The FDA’s list of negative reactions to metal particles in the bloodstream include skin rashes, cardiomyopathy, problems with sight and hearing, depression, decline in mental faculties, renal failure, and thyroid complications.

If you or someone you love has suffered from a DePuy ASR Hip Replacement device, you may be entitled to receive compensation for your medical expenses, lost wages, pain, and suffering.

For a free legal evaluation about your DePuy ASR Hip case and to learn more about filing a DePuy ASR Hip Replacement lawsuit, contact a lawyer at Carey Danis & Lowe by calling 800.721.2519.

First Trials for Defective DePuy ASR Hip Replacement System Set for January 2013

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

First Trials for Defective DePuy ASR Hip Replacement System Set for January 2013A state case regarding the recalled DePuy ASR hip replacement system is scheduled to go to trial in January 2013 in Prince George’s County, Maryland. If DePuy does not settle with plaintiffs before trials begin, the Maryland court will hear three cases regarding health complications related to DePuy’s ASR hip implants.

In August 2012, DePuy, a subsidiary of Johnson & Johnson, settled state cases in Nevada regarding defective ASR hip replacement lawsuits. Trials for these ASR hip replacement cases filed against DePuy were scheduled to begin in December 2012, but due to the settlement, trial dates have since been canceled. The individuals in each Nevada case received $200,000 each, according to a Bloomberg News report.

In 2010, due to what they claimed to be poor sales as opposed to the escalating reports of ASR hip replacement failures, Johnson & Johnson’s DePuy initiated a worldwide recall of 93,000 ASR hip replacement systems. Ultimately, DePuy admitted that the recall was the result of the high ASR hip replacement failure rate.

Individuals who have filed lawsuits against DePuy have claimed that DePuy’s defective ASR hip replacement system resulted in numerous painful revision surgeries, severe pain, dislocated joints, joint malfunction and dislocation, infection, bone fractures, and metallosis. Plaintiffs claim that the unique design of the ASR hip replacement, being a metal-on-metal total hip replacement, led to an accumulation of metal flakes inside of the body.

6,000 DePuy ASR hip replacement lawsuits have been consolidated into a Multi-District Litigation based in Toledo, Ohio overseen by U.S. District Judge David A. Katz. There are another 2,000 cases filed against Johnson & Johnson’s DePuy in states across the U.S., including those in Nevada, Maryland, California, Wisconsin, Florida, and Utah.

The MDL No. 2197 based in Ohio is due to convene for a Status Conference in January 2013, during which time the court will most likely detail preparations for the first bellwether trials scheduled to begin in May 2013.

To file a DePuy ASR hip replacement lawsuit, contact an experienced defective medical device lawyer at Carey Danis & Lowe.

Stryker Recalls Rejuvenate and ABG II Modular Hip Replacement Systems

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

Stryker Recalls Rejuvenate and ABG II Modular Hip Replacement SystemsIn July 2012, Stryker issued a press release with information about a voluntary recall of its Rejuvenate modular-neck stems and its ABG II modular-neck stems, both of which are hip replacement systems manufactured and marketed by Stryker. The medical device manufacturer made the decision to voluntarily recall the Rejuvenate and ABG II hip replacement systems due to reports of fretting and corrosion as well as severe inflammation of adjacent tissues.

In the Stryker recall press release, Stuart Simpson, Stryker’s Vice President and General Manager, Hip Reconstruction, states that, “given the potential risks associated with fretting and corrosion at the modular neck junction, Stryker Orthopaedics decided to take this voluntary action.”

If you or someone you love is currently experiencing pain or swelling in the hip area where a recent surgical procedure was conducted involving either the Rejuvenate Modular hip replacement system or the ABG II Modular hip replacement system, it is highly recommended that you or your loved one see your doctor immediately.

For a free legal consultation regarding a Stryker hip replacement lawsuit, contact an experienced defective medical device lawyer at Carey Danis & Lowe. Our lawyers understand the importance of upholding consumer protection, and in doing so, provide clients with expert legal counsel in Stryker hip replacement lawsuits.

Call a defective medical device lawyer at Carey Danis & Lowe today at 800.721.2519.

Zimmer Issued Warning from FDA Regarding Hip Replacement System

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

Zimmer Issued Warning from FDA Regarding Hip Replacement SystemIn a letter from the U.S. Food and Drug Administration (FDA) dated September 19, 2012, Zimmer Holdings Inc. was issued a warning regarding their hip replacement device known as the Trilogy Acetabular System. The letter of warning followed a recent FDA inspection of a Zimmer Holdings Inc. plant located in Puerto Rico.

The FDA observed while at Zimmer’s Puerto Rican plant that the medical device manufacturer had not established proper testing methods for the hip replacement device. The FDA requires that measures for testing be pursued in order to determine if medical devices conform with design mandates and manufacturing requirements.

The FDA letter also noted that Zimmer had neglected to thoroughly inspect and test the impact of manufacturing methods on their Triology hip replacement devices featuring metallic spikes, which are used as anchoring devices in cases where the use of more traditional materials such as screws and cement is unavailable.

Furthermore, the FDA’s warning letter to Zimmer specifically targeted the medical device manufacturer’s inability to provide test data regarding porosity and pore size in their Trilogy Acetabular Cup hip replacements. Zimmer’s design, according to the manufacturer, is intended to promote adherence of the hip replacement device to the adjacent bones without having to use cement, and this adhesion is aided by the porosity and pore size of the hip replacement medical device. However, as the FDA has stated, there is no evidence from testing that these design criteria meet existing standards for porosity and pore size in hip replacement medical devices.

If Zimmer fails to make efforts toward correcting these FDA violations, they could face severe punishment, including regulations, seizure, and fines.

Zimmer has run into complications with another of their hip replacement systems, the defective Durom Acetabular Component, or Durom Cup. The Durom Cup features a metal-on-metal design for use in a total hip replacement surgery. In 2008, Zimmer voluntarily pulled the Durom Cup off of the U.S. market due to increased reports from patients and surgeons about defective acetabular cups, and an elevated need for revision surgery.

The failure rate of Zimmer’s Durom Cup hip replacement devices are abnormally high. If you or someone you love has suffered physical, emotional, and financial losses due to a total hip replacement surgery involving the defective Zimmer Durom Acetabular Component, or Durom Cup, please contact an experienced defective hip implant device lawyer at Carey Danis & Lowe today to discuss your case.

DePuy Hip Replacements Require Revision Surgery

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

DePuy Hip Replacements Require Revision SurgeryIn 2010, DePuy recalled two types of hip replacements, the ASR XL Acetabular System and the ASR Hip Resurfacing System. DePuy Orthopaedics is a subsidiary of Johnson & Johnson.

DePuy decided to recall two types of hip replacements due to patients needing a second hip replacement after an unsuccessful first implant.

According to complaints filed with the U.S. Food and Drug Administration (FDA), these two kinds of DePuy hip replacements have been known to fail soon after surgery, and quite often, have caused excruciating pain requiring another hip replacement surgery to remove and replace the defective DePuy hip replacement.

In a statement released by DePuy about the recall of two models of their hip replacement systems, the manufacturer understood there to be a high rate of failure for their ASR hip replacements, with approximately 13% of patients requiring a revision surgery to remove and replace the failed DePuy hip replacement. Revision surgery in many of these patients was a result of the build-up of metal detritus created by the DePuy hip implant.

In March 2010, the Medicines and Healthcare Products Regulatory Agency in Britain released a warning about complications arising from the metal particles created by some types of hip replacements.

The DePuy ASR XL Acetabular System hip replacement is a metal-on-metal hip implant. The high failure rate of the ASR hip replacements is tied to an injurious accumulation of metal shavings, which are created by the metal femoral head, a ball-shaped component, rubbing against the inside of the acetabular component, a metal or ceramic cup. Normally, hip implants should not wear so quickly, nor should they cause such an enormous build-up of harmful metal detritus in the body, damaging to muscles and tissues.

However, the DePuy ASR hip implant has been known to wear at alarmingly fast rates. The poor quality of the DePuy ASR hip implants is the reason for an increased need in revision surgery among patients who received this specific type of implant.

The DePuy ASR XL Acetabular System hip replacement was approved for use in the U.S. by the FDA in 2005. If you or someone you love has received a hip implant of either of the two recalled DePuy hip replacements, you and your loved one may be eligible to receive recompense for your financial losses and emotional and physical suffering.

Know that many other patients are stepping forward and filing complaints with the FDA regarding their defective DePuy hip implants

For a free legal consultation regarding your DePuy hip replacement case, contact an experienced defective hip implant lawyer at Carey Danis & Lowe at 800.721.2519.

Metal-on-Metal Hip Replacements Corrode Faster

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

Published May 13, 2012 by LawsuitInformation.org

Can the fact that metal on metal hips may corrode faster than hips made from traditional materials, be the casue of their early failure?

According to new medical research, metal-on-metal hip replacements may corrode faster than traditional types of artificial hip implants, such as those made from plastic or ceramic.

Experts speculate that the corrosion may be linked to an increased risk of local tissue reactions that require revision or removal of the artificial hip implant.

Researchers examined corrosion on the heads of metal-on-metal hip implants, and compared it to the corrosion found on metal-on-polyethylene implants, which have a plastic liner between the metal femoral head and metal acetabular cup. This study is published in the Journal of Arthroplasty,

Study results revealed that metal-on-metal hips showed more corrosion and that rate of corrosion increased over time.

Cobalt and Chromium Heavy Metals

Metal-on-metal hip replacement femoral heads systems are made from cobalt and chromium, which interface within a metal acetabular cup.

Mechanism of Metallosis

As the metal parts of the ball and cup grind against each other, microscopic metal particles are released into the body, which can cause metallosis, or metal blood poisoning.

Local Tissue Reactions

Researchers found that metal-on-metal implants that had been revised after patients experienced local tissue reactions had higher corrosion scores than those without such tissue problems.

FDA Now Investigates

The FDA has scheduled a meeting of its orthopedic devices advisory board to review the safety of metal hip systems for June 27 and 28.

The committee are to review failure rates, testing for metal ion blood poisoning, imaging methods, local and systemic complications, patient risk factors and considerations for follow-up after surgery.

DePuy ASR Recall

In August 2010, a DePuy ASR metal-on-metal hip recall was issued after data suggested that about one out of eight implants failed within five years. More than 93,000 of the DePuy ASR components were sold worldwide before the recall, with about 40,000 implanted in the United States.

More than 6,000 metal on metal hip replacement victims are pursuing a DePuy ASR hip lawsuit against the manufacturer, Johnson and Johnson.

The plaintiffs are alleging that the implant was not adequately researched and that warnings should have been provided about the risk of metal-on-metal hip poisoning.

DePuy Pinnacle Lawsuits

Hundreds of individuals are currently pursuing a DePuy Pinnacle lawsuit, after experiencing problems with the older metal-on-metal hip implant lawsuits, which has also been linked to a high number of failures.

Other Metal on Metal Hip Lawsuits

Similar product liability lawsuits have also been filed over problems with Wright Conserve metal hips, BioMet M2A-Magnum metal hips and other metal-on-metal hip replacements manufactured by other companies.

Can thousands of injured hip replacement patients be wrong?